#2153986
TRÉITHCHINEÁL AQ 713 BACILLUS AMYLOLIQUEFACIENS (SUBTILIS QST 713 ROIMHE SEO)
BACILLUS AMYLOLIQUEFACIENS (FORMER SUBTILIS QST 713) STRAIN AQ 713
TRÉITHCHINEÁL AQ 713 BACILLUS AMYLOLIQUEFACIENS (SUBTILIS QST 713 ROIMHE SEO)
BACILLUS AMYLOLIQUEFACIENS (FORMER SUBTILIS QST 713) STRAIN AQ 713
lena ndeonaítear údarú Aontais le haghaidh an táirge bhithicídigh aonair “Bioquell HPV-AQ”
granting a Union authorisation for the single biocidal product ‘Bioquell HPV-AQ’
Déan tagairt do chur isteach Lipéadaithe Bioquell HPV-AQ sula ndéantar timthriall a reáchtáil.
Refer to the Bioquell HPV-AQ Labelling insert prior to running a cycle.
Níl Bioquell HPV-AQ beartaithe mar steirileán / díghalrán deiridh do ghléasraí liachta.
Bioquell HPV-AQ is not intended for use as a terminal sterilant/disinfectant for medical devices.
Tá údarú ó AQ Austria ag teastáil ón iarratasóir ar ollscoil phríobháideach.
The applicant for a private university requires authorisation from the AQ Austria.
ECHA opinion of 13 October 2021 on the Union authorisation of “Bioquell HPV-AQ” [Tuairim ó ECHA an 13 Deireadh Fómhair 2021 maidir leis an údarú Aontais le haghaidh “Bioquell HPV-AQ”] (ECHA/BPC/296/2021), https://echa.europa.eu/bpc-opinions-on-union-authorisation
ECHA opinion of 13 October 2021 on the Union authorisation of ‘Bioquell HPV-AQ’ (ECHA/BPC/296/2021), https://echa.europa.eu/bpc-opinions-on-union-authorisation
Tá údarú ón údarás inniúil ag teastáil don iarratasóir ar ollscoil phríobháideach (AQ na hOstaire -an Ghníomhaireacht um Dhearbhú Cáilíochta agus um Chreidiúnú na hOstaire).
The applicant for a private university requires an authorisation from the competent authority (AQ Austria - Agency for Quality Assurance and Accreditation Austria).
Aontaíonn an Coimisiún le tuairim na Gníomhaireachta agus measann sé gurb iomchuí, dá bhrí sin, údarú Aontais le haghaidh “Bioquell HPV-AQ” a dheonú.
The Commission concurs with the opinion of the Agency and considers it therefore appropriate to grant a Union authorisation for ‘Bioquell HPV-AQ’.
Tá Bioquell HPV-AQ le húsáid le modúl galúchán Bioquell mar dhífhabhtán do dhromchlaí agus do rudaí neamhbheo eile in fálta.
Bioquell HPV-AQ is to be used with a Bioquell vaporisation module as a disinfectant for surfaces and other inanimate objects in enclosures.
Tá údarú ón údarás inniúil ag teastáil, AQ na hOstaire (an Ghníomhaireacht um Dhearbhú Cáilíochta agus um Chreidiúnú na hOstaire), chun seirbhísí oideachais i réimse na n-eolaíochtaí feidhmeacha a sholáthar ar leibhéal ollscoile arna maoiniú go príobháideach.
The provision of privately funded university level education services in the area of applied sciences requires an authorisation from the competent authority, the AQ Austria (Agency for Quality Assurance and Accreditation Austria).
An 19 Eanáir 2017, chuir Ecolab Deutschland GmbH iarratas isteach i gcomhréir le hAirteagal 43(1) de Rialachán (AE) Uimh. 528/2012 maidir le táirge bithicídeach aonair ar a dtugtar “Bioquell HPV-AQ” de chineálacha táirgí 2, 3, agus 4, mar a thuairiscítear in Iarscríbhinn V a ghabhann leis an Rialachán sin, agus sholáthair sé daingniú i scríbhinn gur chomhaontaigh údarás inniúil na hÍsiltíre meastóireacht a dhéanamh ar an iarratas.
On 19 January 2017, Ecolab Deutschland GmbH submitted an application, in accordance with Article 43(1) of Regulation (EU) No 528/2012, for authorisation of a single biocidal product named ‘Bioquell HPV-AQ’ of product-types 2, 3 and 4 as described in Annex V to that Regulation, providing written confirmation that the competent authority of the Netherlands had agreed to evaluate the application.
Is í sárocsaíd hidrigine substaint ghníomhach “Bioquell HPV-AQ”, ar substaint í a airítear sa liosta Aontais de shubstaintí gníomhacha formheasta dá dtagraítear in Airteagal 9(2) de Rialachán (AE) Uimh. 528/2012 i gcás chineálacha táirgí 2, 3 agus 4.
‘Bioquell HPV-AQ’ contains hydrogen peroxide as the active substance, which is included in the Union list of approved active substances referred to in Article 9(2) of Regulation (EU) No 528/2012 for product-types 2, 3 and 4.
An 4 Samhain 2021, chuir an Ghníomhaireacht tuairim, an dréacht-achoimre ar shaintréithe an táirge bhithicídigh ( “SPC”) atá ag “Bioquell HPV-AQ” agus an tuarascáil mheasúnaithe deiridh ar an táirge bithicídeach aonair faoi bhráid an Choimisiúin i gcomhréir le hAirteagal 44(3) de Rialachán (AE) Uimh. 528/2012.
On 4 November 2021, the Agency submitted to the Commission an opinion, the draft summary of the biocidal product characteristics ( ‘SPC’) of ‘Bioquell HPV-AQ’ and the final assessment report on the single biocidal product in accordance with Article 44(3) of Regulation (EU) No 528/2012.
Is é conclúid na tuairime go bhfuil an táirge bithicídeach “Bioquell HPV-AQ” incháilithe d’údarú Aontais i gcomhréir le hAirteagal 42(1) den Rialachán sin agus, faoi réir chomhlíonadh an dréacht-SPC, go gcomhlíonann sé na coinníollacha a leagtar síos in Airteagal 19(1) den Rialachán sin.
The opinion concludes that the biocidal product ‘Bioquell HPV-AQ’ is eligible for Union authorisation in accordance with Article 42(1) of that Regulation and that, subject to compliance with the draft SPC, it meets the conditions laid down in Article 19(1) of that Regulation.
Deonaítear údarú Aontais a bhfuil an uimhir údaraithe EU-0027469-0000 aige do Ecolab Deutschland GmbH chun an táirge bithicídeach aonair “Bioquell HPV-AQ” a chur ar fáil ar an margadh agus a úsáid i gcomhréir leis an achoimre ar shaintréithe an táirge bhithicídigh a leagtar amach san Iarscríbhinn.
A Union authorisation with authorisation number EU-0027469-0000 is granted to Ecolab Deutschland GmbH for the making available on the market and use of the single biocidal product ‘Bioquell HPV-AQ’, in accordance with the summary of the biocidal product characteristics set out in the Annex.
In AT: Tá údarú ón údarás inniúil ag teastáil, AQ Austria (an Ghníomhaireacht um Dhearbhú Cáilíochta agus um Chreidiúnú na hOstaire), chun seirbhísí oideachais i réimse na n-eolaíochtaí feidhmeacha a sholáthar ar leibhéal ollscoile arna maoiniú go príobháideach.
In AT: The provision of privately funded university level education services in the area of applied sciences requires an authorisation from the competent authority, the AQ Austria (Agency for Quality Assurance and Accreditation Austria).
ECHA opinion of 14 June 2022 on the Union authorisation of ‘EULA OXI-LIME 23’ [Tuairim ó ECHA an 14 Meitheamh 2022 maidir leis an údarú Aontais le haghaidh ‘Bioquell HPV-AQ’] (ECHA/BPC/342/2021), https://echa.europa.eu/it/opinions-on-union-authorisation
ECHA opinion of 14 June 2022 on the Union authorisation of ‘EULA OXI-LIME 23’ (ECHA/BPC/342/2022), https://echa.europa.eu/it/opinions-on-union-authorisation
(aq) ciallaíonn ‘caipiteal an CIM’ ranníocaíochtaí caipitil comhiomlána agus caipiteal neamhghlaoite atá geallta do CIM, arna ríomh ar bhonn méideanna in-infheistithe tar éis na táillí, na muirir agus na speansais uile a iompraíonn na hinfheisteoirí go díreach nó go hindíreach a asbhaint;
(aq) “capital of the AIF” means aggregate capital contributions and uncalled capital committed to an AIF, calculated on the basis of amounts investible after the deduction of all fees, charges and expenses that are directly or indirectly borne by investors;